By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Leukemia and Lymphoma Society has awarded a $6.3 million grant for research at the University of Cambridge that will use genome-wide analysis to study drug responses used for blood cancer treatment, LLS said Monday.

The grant, which provides $1.25 million per year for five years, was funded under the LLS Marshall A. Lichtman Specialized Center of Research (SCOR) grant program.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.